Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.
Wilder-Smith A, Hombach J, Ferguson N, Selgelid M, O'Brien K, Vannice K, Barrett A, Ferdinand E, Flasche S, Guzman M, Novaes HM, Ng LC, Smith PG, Tharmaphornpilas P, Yoon IK, Cravioto A, Farrar J, Nolan TM. Wilder-Smith A, et al. Lancet Infect Dis. 2019 Jan;19(1):e31-e38. doi: 10.1016/S1473-3099(18)30494-8. Epub 2018 Sep 5. Lancet Infect Dis. 2019. PMID: 30195995 Review.
Edging closer towards the goal of a dengue vaccine.
Wilder-Smith A, Yoon IK. Wilder-Smith A, et al. Expert Rev Vaccines. 2016;15(4):433-5. doi: 10.1586/14760584.2016.1154459. Expert Rev Vaccines. 2016. PMID: 26881780 Free article. No abstract available.
Misguided approach to dengue vaccine risk.
Wilder-Smith A, Hombach J, Cravioto A. Wilder-Smith A, et al. Science. 2019 Nov 29;366(6469):1082-1083. doi: 10.1126/science.aaz6159. Science. 2019. PMID: 31780549 No abstract available.
Vaccine-attributable severe dengue in the Philippines.
Wilder-Smith A, Flasche S, Smith PG. Wilder-Smith A, et al. Lancet. 2019 Dec 14;394(10215):2151-2152. doi: 10.1016/S0140-6736(19)32525-5. Lancet. 2019. PMID: 31839188 No abstract available.
Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?
Parker EPK, Desai S, Marti M, O'Brien KL, Kaslow DC, Kochhar S, Olayinka F, Cravioto A, Nohynek H, Hombach J, Wilder-Smith A. Parker EPK, et al. Lancet Infect Dis. 2022 Apr;22(4):438-440. doi: 10.1016/S1473-3099(22)00178-5. Epub 2022 Mar 9. Lancet Infect Dis. 2022. PMID: 35278358 Free PMC article. No abstract available.
409 results